Financial Data and Key Metrics Changes - For Q4 2025, the company reported FFO as adjusted of $0.47 per share and AFFO of $0.40 per share, with total same-store cash NOI growth of 3.9% [15] - For the full year 2025, FFO as adjusted was $1.84 per share and AFFO was $1.69 per share, with total same-store cash NOI growth of 4% [16] - The company ended the year with a net debt to Adjusted EBITDA ratio of 5.2x and $2.4 billion in liquidity [19] Business Line Data and Key Metrics Changes - Outpatient Medical segment represented over 50% of portfolio income, achieving same-store growth of 3.9% and 91% total occupancy [4][16] - The lab segment ended the year with 1.5% same-store growth and total occupancy of 77%, impacted by the Gateway acquisition [17] - Senior Housing segment reported 12.6% same-store growth, significantly above guidance, with 16.7% growth in Q4 [18] Market Data and Key Metrics Changes - The Bay Area led all Life Science markets in Q4 2025 in absorption and leasing activity, with the largest volume of current tenant demand [8] - The private market is recognizing the favorable operating environment, driving down cap rates [5] Company Strategy and Development Direction - The merger with Physicians Realty Trust has created a strong platform in the Outpatient sector, allowing for profitable internalization of property management [4] - The company is focusing on strategic acquisitions, including a 1.4 million sq ft campus in South San Francisco, to capitalize on recovery in the sector [8] - Plans to create a pure-play Senior Housing REIT through the Janus Living IPO, contributing the entire Senior Housing portfolio to capture value [10][11] Management's Comments on Operating Environment and Future Outlook - Management noted an inflection point in the Life Science sector, with signs of recovery in capital raising and M&A activity [6] - The company expects FFOs adjusted to range from $1.70-$1.74 per share for 2026, with same-store NOI growth forecasted between -1% to +1% [19] - Management expressed optimism about improving occupancy in the lab segment, contingent on favorable capital market conditions [30] Other Important Information - The company has completed $464 million in acquisitions so far in 2026, including a $314 million buyout of a joint venture partner in the Senior Housing portfolio [21] - The company plans to execute a capital recycling plan of $1 billion or more in asset sales and recapitalizations in 2026 [21] Q&A Session Summary Question: Can you discuss the Gateway acquisition and its complement to the existing portfolio? - Management expressed excitement about the Gateway acquisition, viewing it as an opportunity rather than a vacancy issue, and highlighted the strategic fit within their existing footprint [25][26] Question: What is the expected cadence of lab occupancy throughout the year? - Management indicated that total occupancy should improve by year-end 2026, depending on continued positive trends in capital markets [30] Question: Can you provide more details on the lab leasing activity? - Management noted that the pipeline is strong, with a mix of new leasing and renewals, and emphasized a significant improvement compared to the previous year [36] Question: What is the impact of lab occupancy losses on 2026 FFO? - Management clarified that the $0.12 impact on earnings is due to various factors, including occupancy losses and higher refinancing costs [41] Question: How are negotiations for 2026 expirations progressing? - Management reported that a substantial majority of expirations are in South San Francisco, where they have strong tenant relationships, and they are optimistic about renewals [61]

Financial Data and Key Metrics Changes - For Q4 2025, the company reported FFO as adjusted of $0.47 per share and AFFO of $0.40 per share, with total same-store cash NOI growth of 3.9% [15] - For the full year 2025, FFO as adjusted was $1.84 per share and AFFO was $1.69 per share, with total same-store cash NOI growth of 4% [16] - The company ended the year with a net debt to adjusted EBITDA ratio of 5.2x and $2.4 billion in liquidity [19] Business Line Data and Key Metrics Changes - Outpatient medical segment represented over 50% of portfolio income, achieving 3.9% same-store growth and 91% total occupancy [3][16] - The lab segment ended the year with 1.5% same-store growth and total occupancy of 77%, impacted by the recent Gateway acquisition [17] - Senior housing segment reported 12.6% same-store growth, with 16.7% growth in Q4, driven by favorable supply and demand fundamentals [18] Market Data and Key Metrics Changes - The outpatient sector is benefiting from a shift in care delivery to lower-cost outpatient settings, supported by policy changes from CMS [4] - The Bay Area led all life science markets in Q4 2025 in absorption and leasing activity, with significant tenant demand [8] Company Strategy and Development Direction - The company is focused on strengthening its portfolio through strategic acquisitions, including the Gateway acquisition and the formation of a pure-play senior housing REIT, Janus Living [10][11] - The company plans to recycle capital through $1 billion or more in asset sales and recapitalizations in 2026 [21] - The company aims to leverage its strong market position and relationships to capture demand as the life science sector recovers [6] Management's Comments on Operating Environment and Future Outlook - Management noted an improvement in capital raising and M&A activity, indicating early signs of a recovery in the life science sector [5] - The company expects FFOs adjusted to range from $1.70 to $1.74 per share for 2026, with total same-store NOI growth forecasted between -1% to +1% [19] - Management highlighted the importance of maintaining a strong balance sheet and disciplined capital allocation to pursue strategic investments [19] Other Important Information - The company has $360 million of additional relationship-driven acquisitions in its senior housing pipeline, expected to close in Q1 2026 [12] - The company filed a confidential S-11 with the SEC for the Janus Living IPO, with expectations to close the offering in the first half of 2026 [13] Q&A Session Summary Question: Can you discuss the Gateway acquisition and its complement to the existing portfolio? - Management expressed excitement about the Gateway acquisition, viewing it as an opportunity rather than just taking on vacancy, and highlighted the strategic fit within their existing footprint [25][26] Question: What is the outlook for lab segment occupancy throughout the year? - Management indicated that total occupancy should improve by year-end 2026, contingent on continued positive trends in capital markets [28][30] Question: Can you provide details on the lab leasing activity under execution or LOI? - Management noted that the current pipeline is significantly improved compared to the previous year, with a shift towards new leasing [34][35] Question: What is the impact of lab occupancy losses on 2026 FFO? - Management clarified that the $0.12 impact on earnings is due to various factors, including occupancy losses and higher refinancing costs [41][42] Question: How is the company addressing the 2026 expirations for life science? - Management stated that a substantial majority of expirations are in South San Francisco, where they have strong tenant relationships, and they are optimistic about capturing renewals [61][62]

Core Viewpoint - Healthpeak Properties (DOC) has been identified as a stock that the analyst initially rated as a Buy when it was trading at $18 per share, but the performance has not met expectations [1]. Group 1: Investment Strategy - The analyst has continued to accumulate shares of Healthpeak as the stock price dipped, indicating a belief in its long-term potential despite short-term challenges [1]. - The investment approach combines growth stocks, quality stalwarts, and dividend growth strategies to create a balanced portfolio aimed at outperforming the market [1]. Group 2: Future Plans - The analyst intends to exit the position in Healthpeak Properties and reallocate funds to higher-quality Real Estate Investment Trusts (REITs) as the stock approaches its fair value multiple [3].

Core Insights - Wall Street analysts anticipate Ventas (VTR) will report quarterly earnings of $0.89 per share, reflecting a year-over-year increase of 9.9% [1] - Expected revenues for Ventas are projected at $1.49 billion, which represents a 16.1% increase from the same quarter last year [1] - There has been a slight downward revision of 0.2% in the consensus EPS estimate over the last 30 days, indicating a reassessment by analysts [1] Revenue Estimates - Analysts estimate 'Revenues- Interest and other income' will reach $2.25 million, indicating a significant year-over-year decline of 72.9% [4] - The 'Revenues- Rental income- Outpatient medical & research portfolio' is projected to be $229.22 million, reflecting a 6% increase from the prior-year quarter [4] - 'Revenues- Resident fees and services' are expected to total $1.11 billion, showing a year-over-year increase of 23.4% [5] Depreciation and Returns - Analysts project 'Depreciation and amortization' to be approximately $361.19 million [5] - Over the past month, shares of Ventas have returned +1.3%, compared to a +1.8% change in the Zacks S&P 500 composite [5] - With a Zacks Rank of 4 (Sell), VTR is expected to underperform the overall market in the near future [5]

Core Insights - Healthpeak Properties, Inc. reported fourth-quarter 2025 funds from operations (FFO) as adjusted per share of 47 cents, exceeding the Zacks Consensus Estimate of 45 cents and slightly up from 46 cents in the prior-year quarter [1][8] - The company generated revenues of $719.4 million, surpassing the Zacks Consensus Estimate of $699.5 million, reflecting a year-over-year increase of 3.1% [2] - Full-year FFO, as adjusted, was $1.84 per share, above the Zacks Consensus Estimate of $1.83, and improved 1.7% year over year [2] Financial Performance - Healthpeak reported a 3.9% year-over-year growth in total merger-combined same-store cash (adjusted) net operating income (NOI) [4] - The outpatient medical and continuing care retirement community (CCRC) segments experienced year-over-year growth of 4.1% and 16.7%, respectively, while the lab segment saw a decline of 0.3% [4] - Interest expenses increased by 14.4% year over year to $80.6 million [5] Strategic Initiatives - The company announced the formation of Janus Living, Inc., a senior housing REIT, and plans for an initial public offering (IPO) [3] - Healthpeak is restructuring its portfolio by selling stabilized assets and reinvesting the proceeds into value-accretive investments [3] - The company is focusing on technology innovation initiatives to enhance automation, decision-making speed, and client service [3] Balance Sheet - Healthpeak ended the fourth quarter with cash and cash equivalents of $467.5 million, a significant increase from $91 million as of September 30, 2025 [6] - The net debt to adjusted EBITDAre ratio was 5.2X as of December 31, 2025 [6] 2026 Outlook - The company expects FFO as adjusted per share to be between $1.70 and $1.74, while the Zacks Consensus Estimate is currently at $1.84 [7] - Total merger-combined same-store cash (adjusted) NOI growth is projected to range from negative 1% to 1% [7]

Financial Data and Key Metrics Changes - The company reported earnings available for distribution of $2.35 per diluted share, representing a 12% year-over-year growth [13] - GAAP net income for the year was $567 million, with a return on equity of 8% [14] - Book value at the end of the year was reported at $7 billion, equating to $12.60 per common share, an increase from the previous year [15][16] Business Line Data and Key Metrics Changes - The Genesis business produced just under $5 billion in loans, with earnings up 250% since its acquisition in 2022 [8] - Newrez, the mortgage company, saw year-over-year earnings growth of 13% [8] - Sculptor's AUM grew from $34 billion to $38 billion, with gross inflows of $5.8 billion in 2025 [17][26] Market Data and Key Metrics Changes - The company manages over $100 billion in investable assets, with $63 billion in Rithm Asset Management AUM and $53 billion in balance sheet business [11] - The 10-year Treasury yield increased to approximately 4.30%, while mortgage rates have slightly decreased [16] - San Francisco recorded approximately 9 million sq ft of leasing activity, the strongest annual total since 2019, indicating a recovery in the market [37][39] Company Strategy and Development Direction - The company aims to grow prudently by creating alpha and results for clients, focusing on performance-driven asset management [6][11] - The acquisition of Paramount is seen as a transformational move into the commercial real estate space, with a focus on Class A office buildings [30][32] - Investments in technology and marketing are prioritized to enhance customer experience and operational efficiency [9][46] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the recovery in the San Francisco market, particularly driven by AI companies and a return to office momentum [35][39] - The company anticipates a continued steepening of the yield curve, which could benefit its operations [22] - Management remains cautious about competition in the mortgage space, emphasizing a disciplined approach to origination and market share [60][65] Other Important Information - The company has made significant investments in technology, including partnerships with Valon and HomeVision to enhance its servicing and underwriting capabilities [46][47] - The company has a strong focus on maintaining high-quality tenant relationships and enhancing amenities in its real estate portfolio [39] Q&A Session Summary Question: Can you detail the funded volumes, particularly the refi percentage? - The increase in refi volume was driven by market conditions, including a rally in late summer and tighter spreads, leading to expectations of continued growth in the first quarter [58][59] Question: What is the company's view on competition in the mortgage space? - The company acknowledges the competitive nature of the mortgage business but emphasizes its focus on maintaining margins and not engaging in irrational pricing wars [63][65] Question: How did the gain on sale margin improve in the retail channel? - The improvement was attributed to a favorable mix and timing of completions, alongside a focus on maintaining margins in the consumer direct channel [70]

Financial Data and Key Metrics Changes - The company reported earnings available for distribution of $2.35 per diluted share for 2025, representing a 12% year-over-year growth [13] - GAAP net income for Q4 was $53 million, or $0.09 per diluted share, with a 3% return on equity [14] - For the full year, GAAP net income was $567 million, with a return on equity of 8% [14] - Book value at the end of 2025 was reported at $7 billion, or $12.60 per common share, an increase from the previous year [15] Business Line Data and Key Metrics Changes - The Genesis business produced just under $5 billion in loans, with earnings up 250% since its acquisition in 2022 [8] - Newrez, the mortgage company, saw year-over-year earnings growth of 13% [8] - Sculptor's AUM grew from $34 billion to $38 billion in 2025, with gross inflows of $5.8 billion [17][26] Market Data and Key Metrics Changes - The 10-year treasury yield increased to approximately 4.30%, while mortgage rates have slightly decreased [16] - In San Francisco, leasing activity increased by 330% year-over-year, with the market showing signs of recovery [37] - The New York core portfolio's leased occupancy was 92.8%, up 780 basis points year-over-year [34] Company Strategy and Development Direction - The company aims to grow prudently by creating alpha and results for clients, focusing on performance-driven asset management [6] - The acquisition of Paramount is seen as a transformational move into the commercial real estate space, with a focus on Class A office buildings [30][32] - Investments in technology and marketing are prioritized to enhance customer experience and brand [9] Management's Comments on Operating Environment and Future Outlook - Management noted significant geopolitical risks but expressed optimism about the mortgage market's recovery and the potential for increased origination gains [21][22] - The company expects a 10% increase in production for 2026, aligning with market estimates [59] - Management emphasized the importance of maintaining pricing discipline and not chasing market share in a competitive environment [60][65] Other Important Information - The company has made significant investments in technology partnerships, including with Valon Technologies and HomeVision, to enhance operational efficiency [46][47] - The firm has a strong focus on maintaining relationships with tenants and brokers to secure renewals and fill vacancies in its real estate portfolio [39] Q&A Session Summary Question: Can you detail the funded volumes, particularly the refi percentage? - The increase in refi volume was driven by market conditions, with a notable rally in late summer and September leading to higher production [58] Question: What are the expectations for overall volumes in Q1? - The forecast for 2026 is expected to be up around 10%, with continued improvements in service and tools for homeowners [59] Question: Can you discuss competition in the mortgage space? - The mortgage business remains competitive, with some players being aggressive, but the company focuses on maintaining margins and not engaging in irrational pricing [63][65] Question: How did the retail channel perform in terms of gain on sale margin? - The improvement in margins was influenced by a mix shift and timing of MSR recapture, with a focus on maintaining overall margins [70] Question: How did wholesale volumes perform despite competition? - The company maintained a disciplined approach to margins while focusing on non-agency production, which has been a key growth area [72]

An MSR-Focused REIT Fourth Quarter Earnings Call Presentation February 3, 2026 Safe Harbor Statement FORWARD-LOOKING STATEMENTS This presentation of Two Harbors Investment Corp., or TWO, includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, readers should not rely on these forward-looking statements as predictions of ...

Core Insights - AI stocks have gained significant attention due to the increasing demand for chips used in AI model and application development [1] - Infrastructure is essential for supporting AI hardware and data transmission, aligning with American Tower's strategy to build data centers for AI workloads [2] Company Overview - American Tower is one of the largest REITs globally, owning and operating over 149,000 multitenant communications sites and a network of U.S. data centers [3] - The company acquired CoreSite for $10.1 billion in 2021, adding 25 data centers across eight major U.S. markets to its portfolio [4] Strategic Developments - The acquisition of CoreSite was initially aimed at supporting 5G deployment, but the focus has shifted to developing data centers for AI applications [5] - CoreSite recently launched 400 Gbps (400G) Amazon Web Services (AWS) Direct Connect at its Chicago campus, enhancing its capability for high-bandwidth AI workloads [5] Market Applications - CoreSite's 400G connectivity is already being utilized by a leading cybersecurity firm for real-time threat analysis [6] - Financial firms are exploring 400G for high-speed trading and quantitative research, positioning American Tower's data centers as a potential asset for enhancing returns [7]

Core Viewpoint - Federal Realty Investment Trust (FRT) is recognized as a "Dividend King" with a current yield of 4.4% and anticipates total growth of 6.8% for the fiscal year, primarily driven by strong leasing activity [1] Company Summary - FRT has a current dividend yield of 4.4% [1] - The company expects a total growth rate of 6.8% for the fiscal year [1] - Strong leasing activity is cited as the main factor contributing to this growth [1]